RT
WST icon

Rockland Trust’s West Pharmaceutical WST Stock Holding History

Rockland Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
2,956
-1,287
-30% -$393K 0.04% 142
2026
Q1 		$1.06M Sell
4,243
-1,920
-31% -$478K 0.04% 141
2025
Q4 		$1.7M Sell
6,163
-76,903
-93% -$21M 0.07% 116
2025
Q3 		$21.8M Buy
83,066
+5,087
+7% +$1.24M 0.89% 37
2025
Q2 		$17.1M Buy
77,979
+13,255
+20% +$2.83M 0.83% 40
2025
Q1 		$14.5M Buy
64,724
+4,980
+8% +$1.37M 0.73% 44
2024
Q4 		$19.6M Buy
59,744
+3,102
+5% +$976K 1% 34
2024
Q3 		$17M Buy
56,642
+3,055
+6% +$936K 0.84% 41
2024
Q2 		$17.7M Buy
53,587
+1,153
+2% +$407K 0.93% 35
2024
Q1 		$20.7M Buy
52,434
+400
+0.8% +$148K 1.09% 32
2023
Q4 		$18.3M Buy
52,034
+243
+0.5% +$86K 1% 35
2023
Q3 		$19.4M Sell
51,791
-574
-1% -$222K 1.17% 27
2023
Q2 		$20M Sell
52,365
-1,021
-2% -$365K 1.2% 25
2023
Q1 		$18.5M Buy
53,386
+7,316
+16% +$2.14M 1.16% 25
2022
Q4 		$10.8M Sell
46,070
-3,780
-8% -$896K 0.69% 51
2022
Q3 		$12.3M Buy
49,850
+1,446
+3% +$441K 0.88% 43
2022
Q2 		$14.6M Buy
48,404
+47,130
+3,699% +$15.3M 1.01% 32
2022
Q1 		$523K Buy
1,274
+26
+2% +$10.2K 0.03% 202
2021
Q4 		$585K Sell
1,248
-245
-16% -$105K 0.04% 196
2021
Q3 		$634K Hold
1,493
– – 0.04% 181
2021
Q2 		$536K Buy
+1,493
New +$493K 0.04% 193

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Rockland Trust's WST Position: Q2 2026 in Review

Rockland Trust reduced its West Pharmaceutical (WST) stake by 30% in Q2 2026, selling an estimated $393K and leaving 2,956 shares worth $1.06M. The position accounts for 0.04% of the portfolio, ranked #142.

Rockland Trust first reported a position in WST in Q2 2021 and has held it in 21 quarters since. The position peaked at $21.8M in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Rockland Trust held 2,956 shares of West Pharmaceutical worth $1.06M as of Q2 2026.
  • Rockland Trust sold 1,287 West Pharmaceutical shares in Q2 2026, an estimated $393K.
  • West Pharmaceutical made up 0.04% of Rockland Trust's portfolio in Q2 2026, its #142 holding.
  • Rockland Trust first reported a position in West Pharmaceutical in Q2 2021 and has held it in 21 quarters since.
  • Rockland Trust's West Pharmaceutical position peaked at $21.8M in Q3 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.